ArticleFrontiers in molecular medicine2026

CD19 exon 2 skipping is a potential prognostic correlate of anti-CD19 CAR-T therapy relapse.

Søren Helweg Dam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.